Abstract:Objective To identify the T cell epitopes from ovarian cancer associated anti-idiotypic antibody 6B11in order to explore the molecular basis of 6B11 induced cellular immune responses against ovarian cancer.Methods Potential human leukocyte antigen(HLA)A0201 ligands were predicted by using SYFPEITHI algorithm and tested by the T2 binding assay for screening of HLA-A2 binding peptides from 6B11 complimentary determining region(CDR).Cytotoxic T lymphocytes(CTL)to 6B11 or peptides were generated by 3 rounds of in vitro stimulation with 6B11 or peptide-pulsod dendritic cells(DC),and then tested by 51Cr-release assay to ascertain the CTL epitope of 6B11.Cell proliferation assay was performed by using 6B11 specific CTL as responder cells and peptide-pulsed DC as stimulators to ascertain the helper T lymphocyte(Th)epitope of 6B11.Cytokine assay and interferon-γ ELISPOT assay were performed to verify the CTL and Th epitope of 6B11 further.Results Light chain CDR3 peptide(VL CDR3)of 6B11 induced specific CTL to kill HLA-A2 and target antigen positive ovarian cancer cells,which could be blocked by anti human major histocompatibility complex(MHC)Ⅰ antibody.Heavy chain CDR3 peptide(VH CDR3)of 6B11 stimulated the proliferation of 6B11-primed CTL,which could be blocked mainly by anti human MHC-Ⅱ antibody,and further experiments showed that part of the VH CDR3 peptide-primed CTL killed K562 cells.Peptides in VL CDR3 and VH CDR3 were the CTL and Th epitope mimicking the original antigen of 6B11 respectively.Collaboration of 6B11 CTL and Th epitope,or 6B11 CTL epitope and keyhole limpet hemocyanin(KLH),the former was more powerful in inducing specific cellular immune responses against ovarian cancer.6B11 or corresponding CTL and Th epitope specific CIL secreted high levels of interleukin-2 (1630,1503 ng/L)and interferon-γ(5620,5421 ng/L),while basal level of interleukin-4 was detected (253,274 ng/L).ELISPOT assay confirmed the existence of specific interferon-γ secreting cells in 6811 or epitopes specific CTL(196/1×106 T cell,184/1×106 T cell).Conclusions VL CDR3 and VH CDR3 peptides of 6B11 are the CTL and Th epitopes mimicking original antigen which could duplicate the activity of intact 6B11 to induce the cellular immune responses against ovarian cancer.The results have significant theoretical and practical value in application of anti-idiotypic antibody ag anti tumor vaccine.The acquired CTL and Th epitopes as constituents of future multiple peptides against ovarian cancer could be used in peptide vaccine based ovarian cancer therapy.

Humanization of Ovarian Carcinoma Anti-idiotype Single-chain (V_L-V_H-CH3) Antibody

The Construction and Expression of Humanized Anti- Idiotypical Antibody Mimic to Ovarian Carcinoma Antigen

Preparation Of Humanized Ovarian Carcinoma Anti-Idiotypic Minibody

[Immuno-Therapeutic Study of Anti-Idiotype Minibody (single Chain Fv-CH3) on Ovarian Carcinoma Bearing Mice].

Expression of an Ovarian Cancer Anti-Idiotype Antibody (6b11vlvhch3) in Chinese Hamster Ovary (cho) Cells with Improved Immunoactivity and Stability over Proteins Expressed in Prokaryotic Cells

Study of anti-idiotype vaccine against ovarian carcinoma

Successful construction and massive expression of a novel Anti-CD19 human-mouse chimeric antibody Hm2E8b.

Construction,expression,and Identification of Ovarian Anti-Idiotypic Single Chain Antibody 6b11scfv and Mouse HSP70 Fusion Protein

Construction and Expression of a Single-Chain Bispecific Antibody COC183B2/anti-CD3 Against Human Ovarian Carcinoma

Humoral Immune Responses Induced By Anti-Idiotypic Antibody Fusion Protein Of 6b11scfv/Hgm-Csf In Balb/C Mice

Construction and Expression of a Human/mouse Chimeric CD19 Monoclonal Antibody: Successful Modification of a Murine IgM to a Chimeric IgG.

High Level Expression of 3D5 Ovarian Carcinoma Anti-idiotypic Single-Chain Antibody (3D5ScFv) in E.coli

Construction and Expression of Single-Chain Antibody Derived from a New Clone of Monoclonal Antibody Against Human CD14 in CHO Cells

Anti-ovarian Tumor Immune Responses Induced by the Fusion Protein of Anti-Idiotypic Single Chain Antibody-Heat Shock 70 in Vitro

Preparation of the Anti-Human Chorionic Gonadotrophin Β-Subunit Monoclonal Antibodies Based on the Genetic Immunization with Recombinant Plasmid and Characterization of Its Biological Properties

Purification and Characterization of 6C6 Mouse-human Chimeric-antibody

New T cell epitopes identified from an anti-idiotypic antibody mimicking ovarian cancer associated antigen

THE STUDY OF EXPRESSION AND FUNCTION OF ANTIBODY-CYTOKINE FUSION PROTEIN 183B2scfv-Interleukin 2

Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody

[In Vivo Study of Antitumor Immune Responses Induced by Anti-Idiotypic Minibody Vaccine of Ovarian Cancer].

Some Characteristics and Purification of Anti-(Human Ovarian Carcinoma) X Anti-(Human Cd3) Single-Chain Bispecific Antibody